Clinical Trials
43 trialsDCP-NDM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Scheduled Meditation for Improving Postoperative Outcomes in Patients Undergoing Pancreatectomy
City of Hope Medical Center
64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer
City of Hope Medical Center
The Canopy Cancer Collective Clinical Registry Protocol
Canopy Cancer Collective, LLC
BRIDGE-8
Soonchunhyang University Hospital
DCP-DM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer
M.D. Anderson Cancer Center
ОС26
Military Medical Clinical Center of the Southern Region, Ukraine
BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
Northwestern University
SUNRISE
AdventHealth Translational Research Institute
K4CARE-PDAC
Chang Gung Memorial Hospital
A Study of DCTY1102 Injection in Participants With Advanced Solid Tumors
Beijing DCTY Biotech Co.,Ltd.
A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer
Lepu Biopharma Co., Ltd.
An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer
Shandong Suncadia Medicine Co., Ltd.
Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
M.D. Anderson Cancer Center
ODI-2001-01
Centre Georges Francois Leclerc
PANACEA
Marker Therapeutics, Inc.
NUMANTIA-2
Nelum Corp
Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
ChefHat-001
BigHat Biosciences, Inc.
PREDIPER
Assistance Publique - Hôpitaux de Paris
MRinRT
Swansea Bay University Health Board
ResQ108B-PANC
ImmunityBio, Inc.
E-FACTOR
Centre Leon Berard
A Prospective Non-randomized Controlled Interventional Study on the Effect of Shouhui Tongbian Capsules Combined With Pancreatin Enteric-coated Capsules on Pancreatic Exocrine Function in Patients After Curative Resection for Pancreatic Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Chimeric Antigen Receptor Macrophages Targeting c-MET for Advanced Stage of Pancreatic Cancer Patients
Peking Union Medical College Hospital
Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
Ruijin Hospital
e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients
University of Miami
A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer
Rgene Corporation
Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer
University of Arkansas
ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer
Anova Innovation Limited
Evaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening
M.D. Anderson Cancer Center
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer
University of Maryland, Baltimore
MIND-PANC
Shanghai Zhongshan Hospital
SURGIMEDIA
UNC Lineberger Comprehensive Cancer Center
PRE-PDAC
Catholic University of the Sacred Heart
Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
Recurv Pharma Inc
PAN-Plastic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
HY-PANC
Universidad Europea de Madrid
PRISM-TAMP
University of Vermont
Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
Sun Yat-sen University
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
Huazhong University of Science and Technology